Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis

Remission induction in antineutrophil cytoplasmic autoantibody (ANCA) vasculitis may be complicated by slow response to treatment and toxicity from glucocorticoids. We describe outcomes with a novel remission induction regimen combining rituximab with a short course of low-dose, oral cyclophosphamid...

Full description

Bibliographic Details
Main Authors: Frank B. Cortazar, Saif A. Muhsin, William F. Pendergraft, III, Zachary S. Wallace, Colleen Dunbar, Karen Laliberte, John L. Niles
Format: Article
Language:English
Published: Elsevier 2018-03-01
Series:Kidney International Reports
Subjects:
ANCA vasculitis
cyclophosphamide
remission
rituximab
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024917304394

Internet

http://www.sciencedirect.com/science/article/pii/S2468024917304394

Similar Items